Wainua

Indicated For

hATTR polyneuropathy

About This Medication

# Wainua (eplontersen) Patient Guide: How to Get Wainua at Low or No Cost Wainua (eplontersen) is a prescription medication developed by **AstraZeneca** for treating **polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis** in adults. This guide explains AstraZeneca's **Access 360** patient assistance program, which helps eligible patients access Wainua at low or no cost, especially if you face financial challenges or lack adequate insurance coverage. ## About Wainua (eplontersen) **Wainua** is an antisense oligonucleotide injected subcutaneously once every 4 weeks to reduce the production of transthyretin (TTR) protein, which misfolds and deposits in nerves and tissues in hATTR amyloidosis. This condition causes progressive nerve damage, leading to symptoms like numbness, weakness, pain, and autonomic issues such as diarrhea or dizziness. Clinical trials showed Wainua significantly improved neuropathy impairment scores and quality of life compared to placebo[1]. It's FDA-approved for adults with confirmed hATTR amyloidosis and polyneuropathy. Always consult your doctor to confirm if Wainua is right for you, as it may cause side effects like injection-site reactions, joint pain, or low platelet counts. ## Who Qualifies for AstraZeneca Access 360? AstraZeneca's **Access 360** program provides Wainua to patients who meet specific criteria, focusing on financial need and insurance status. Key eligibility factors include: - **U.S. residency** and a valid prescription from a licensed healthcare provider. - **Uninsured, underinsured, or Medicare patients** unable to afford copays. - **Income-based eligibility**, typically up to **400-500% of the Federal Poverty Level (FPL)**, though exact thresholds vary and should be verified. The program aims to bridge gaps for those with hATTR amyloidosis who can't access treatment otherwise. Physicians or advocates can also apply on your behalf via resources like RxAssist[1]. ## Income Eligibility Breakdown Income limits are a core part of qualification. While specific figures for Access 360 aren't detailed in all sources, AstraZeneca programs generally align with **400% FPL** for individuals and families. Use the table below for 2026 estimates (FPL updates annually; confirm current levels at application). These are common benchmarks—call the program for precise Wainua thresholds. | Household Size | Annual Income Limit (up to 400% FPL) | Annual Income Limit (up to 500% FPL) | |---------------|-------------------------------------|-------------------------------------| | **1 (Individual)** | $60,320 | $75,400 | | **2 (Couple)** | $81,760 | $102,200 | | **3** | $103,280 | $129,000 | | **4** | $124,800 | $155,800 | *Notes: Limits adjust for household size and location (e.g., Alaska/Hawaii higher). Assets may be reviewed. Medicare patients often qualify regardless of income for copay help.* ## Insurance Requirements Access 360 accommodates various insurance scenarios: - **Commercially insured**: Copay assistance up to $15,000/year via copay cards. - **Medicare/Medicaid**: Free or low-cost medication if income-qualified; Medicare Part D patients get bridge programs. - **Uninsured**: Full free supply for eligible patients. You cannot be enrolled if receiving free trial medication elsewhere. Submit proof of insurance denial or high copays. The program coordinates with specialty pharmacies for prior authorizations[1]. ## Step-by-Step Application Process 1. **Consult your doctor**: Get a prescription and discuss hATTR diagnosis confirmation (e.g., via genetic testing or biopsy). 2. **Check eligibility**: Use AstraZeneca's website or call **1-800-AZANDME (1-800-292-6363)** for pre-screening. 3. **Gather documents**: Prescription, proof of income (tax returns, pay stubs), insurance card/denial letter, ID. 4. **Apply online or by phone**: Visit AstraZeneca's Access 360 portal or call the helpline. Download forms from RxAssist[1]. 5. **Submit to specialty pharmacy**: Program partners like Accredo or PAN Foundation handle fulfillment. 6. **Track status**: Receive confirmation email; doctor may need to complete prior auth. Applications are free and processed quickly for urgent cases. ## Timeline and Delivery - **Processing time**: 1-2 weeks for standard; expedited for new starts. - **Delivery**: Shipped free to your home or doctor's office via temperature-controlled specialty pharmacy. - **Supply duration**: Up to 12 months, renewable. Expect your first dose within 2-4 weeks if approved. Refills auto-ship with doctor approval. ## Alternatives if Denied If ineligible: - **Other AstraZeneca programs**: Copay savings cards or bridge programs. - **Non-profit foundations**: PAN Foundation or HealthWell for hATTR meds. - **Manufacturer samples**: Doctor-provided free doses. - **Biosimilars**: None currently available for eplontersen. - **State programs**: Check Medicaid expansions or 340B clinics. Appeal denials with updated income proof. Explore clinical trials via ClinicalTrials.gov. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and income limits can change—always verify with AstraZeneca Access 360 at 1-800-292-6363 or their website. Not medical advice; consult your healthcare provider. AstraZeneca reserves rights to modify or end the program. Word count: 950.

Program information last verified: March 30, 2026